Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
A
Ambey Laboratories Ltd
Score 48/100• Risky
Ambey Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health77/100
Valuation 80/100 · PB 1.3658
Technical Avoid
1M 2.163% 6M 5.556% 1Y -30.966%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#271
View details ➜
A
Amanta Healthcare Ltd
Score 48/100• Risky
Amanta Healthcare Ltd presents a risky investment opportunity due to inconsistent growth and valuation concerns.
Company’s Health58/100
Valuation 40/100 · PB 4.4805
Technical Avoid
1M -8.852% 6M -12.303% 1Y -12.303%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#272
View details ➜
A
Adeshwar Meditex Ltd
Score 48/100• Risky
Adeshwar Meditex Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health64/100
Valuation 100/100 · PB 0.8493
Technical Watch
1M 43.894% 6M 45% 1Y -7.447%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#273
View details ➜
A
Amwill Health Care Ltd
Score 48/100• Risky
Amwill Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
Company’s Health98/100
Valuation 80/100 · PB 1.5029
Technical Avoid
1M 0% 6M -31.812% 1Y -44.236%
Confidence100%
Low leverage (D/E)No promoter pledge
#274
View details ➜
A
Alivus Life Sciences Ltd
Score 48/100• Risky
Alivus Life Sciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health93/100
Valuation 40/100 · PB 4.0688
Technical Avoid
1M -2.09% 6M -5.768% 1Y -22.308%
Confidence100%
Low leverage (D/E)No promoter pledge
#275
View details ➜
A
Albert David Ltd
Score 48/100• Decent
While Albert David Ltd operates in a promising sector, its inconsistent growth and valuation concerns suggest caution for investors.
Company’s Health66/100
Valuation 80/100 · PB 1.1648
Technical Avoid
1M -2.971% 6M -5.049% 1Y -42.424%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#276
View details ➜
G
Godavari Drugs Ltd
Score 48/100• Risky
Godavari Drugs Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment at this time.
Company’s Health52/100
Valuation 80/100 · PB 1.4093
Technical Avoid
1M -1.898% 6M -14.708% 1Y -39.137%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#277
View details ➜
G
Global Longlife Hospital and Research Ltd
Score 48/100• Risky
The stock presents several risks with limited growth potential and profitability concerns, making it a risky investment.
Company’s Health50/100
Valuation 100/100 · PB 0.9795
Technical Avoid
1M 2% 6M 16.233% 1Y -30.583%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#278
View details ➜
G
Glenmark Pharmaceuticals Ltd
Score 48/100• Risky
Glenmark Pharmaceuticals presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
Company’s Health63/100
Valuation 20/100 · PB 6.0407
Technical Avoid
1M -10.315% 6M 37.57% 1Y 4.948%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#279
View details ➜
G
GKB Ophthalmics Ltd
Score 48/100• Risky
GKB Ophthalmics Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health60/100
Valuation 100/100 · PB 0.5846
Technical Avoid
1M -15.379% 6M -2.328% 1Y -37.953%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#280
View details ➜
G
Gennex Laboratories Ltd
Score 48/100• Risky
Gennex Laboratories Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
Company’s Health59/100
Valuation 80/100 · PB 1.6999
Technical Avoid
1M 15.891% 6M 4.345% 1Y -33.603%
Confidence100%
Low leverage (D/E)Healthy profit margins
Weak ROEPromoter pledge present
#281
View details ➜
G
Ganga Pharmaceuticals Ltd
Score 48/100• Risky
Ganga Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health48/100
Valuation 80/100 · PB 1.2105
Technical Avoid
1M — 6M 32.727% 1Y -25.396%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#282
View details ➜
E
Eris Lifesciences Ltd
Score 48/100• Decent
Eris Lifesciences Ltd shows decent potential with consistent growth and profitability metrics, but faces challenges in valuation and execution risks.
Company’s Health69/100
Valuation 20/100 · PB 6.5951
Technical Avoid
1M -4.826% 6M 14.64% 1Y 15.674%
Confidence100%
Healthy profit marginsDecent revenue growth
Weak ROEPromoter pledge present
#283
View details ➜
E
Emmessar Biotech and Nutrition Ltd
Score 48/100• Risky
Emmessar Biotech and Nutrition Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health68/100
Valuation 80/100 · PB 1.9861
Technical Avoid
1M 21.14% 6M -10.641% 1Y -42.366%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#284
View details ➜
E
Eiko Lifesciences Ltd
Score 48/100• Risky
Eiko Lifesciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health84/100
Valuation 80/100 · PB 1.2147
Technical Avoid
1M -6.447% 6M -4.485% 1Y -25.329%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#285
View details ➜
Showing 271 to 285 of 301 (21 Pages)